Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Pharma major plummets over 10% after third trial disappointment in a week

CNBC

BusinessCNBC·Sep 8, 2026·1 min read

Pharma major plummets over 10% after third trial disappointment in a week

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

View original source — CNBC ↗

ShareShare on X Share on Facebook

Related stories

BusinessSep 7, 2026 · 1 min

European Stocks Muted as Oil Prices Climb and Novartis Falls

SpaceX rally loses steam: Stock price falls over 6% after blockbuster debut week at Wall Street

TechnologyJun 19, 2026 · 1 min

SpaceX rally loses steam: Stock price falls over 6% after blockbuster debut week at Wall Street

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

WorldJun 8, 2026 · 1 min

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

WorldJun 8, 2026 · 1 min

Weight loss drug maker sinks 25% after new safety data spooks investors